Organization Profile

You just read:

OncoQuest Receives "Notice of Allowance" for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy for Stage III-IV Ovarian Cancer Patients

News provided by

OncoQuest Inc.

Sep 25, 2019, 07:00 ET